Friday, Oct. 24, 2014. (AP Photo/Pablo Martinez Monsivais, File) Updated [hour]:[minute] [AMPM] [timezone], [monthFull] [day], [year] A common blood test may miss ovarian cancer in some Black and ...

A clinician nudge at the time of a suspected ovarian cancer diagnosis improved gynecologic oncology referral rates by 20 percentage points. A randomized controlled trial of this strategy is planned.

Toon Van Gorp, MD, PhD, discussed findings from the MIRASOL trial and the potential of mirvetuximab to redefine treatment paradigms in ovarian cancer. Mirvetuximab soravtansine-gynx (Elahere) ...

The TROP-2 ADC "demonstrated encouraging durable efficacy and a manageable safety profile in patients with previously treated ovarian cancer," said Maria Rubinstein, MD, of Memorial Sloan ...

Researchers at the University of Pittsburgh have identified a novel trigger of a deadly form of ovarian cancer: a subset of progenitor cells that reside in fallopian tube supportive tissue ...

Cancer that develops in the ovaries (the egg-producing reproductive organs) is referred to as ovarian cancer. There are three types of ovarian cancer. Each type has differences in how they will ...

The ovaries are small organs that make eggs and hormones like estrogen and progesterone. This surgery can help prevent ovarian cancer and might be recommended for people at high risk. When an ...